Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Patentable subject matter Stories

2014-01-24 23:20:21

CRS Advanced Technology prevails in having six claims cancelled in Frontline's '151 patent after petitioning the USPTO to review them under a new procedure enacted by Congress to rid the marketplace of invalid business method patents. Montoursville, PA (PRWEB) January 24, 2014 On January 21, 2014, the United States Patent and Trademark Office (USPTO) issued a final written decision canceling claims 3, 6, 7, 16, 24, and 33 of U.S. Patent Number 6,675,151 (the ‘151 patent), which...

2013-12-12 12:28:39

Atypical Early Win as Judge Invalidates Patent in David vs. Goliath Battle SAN DIEGO, Calif., Dec. 12, 2013 /PRNewswire/ -- On November 22, Judge Denise Cote of the Southern District of New York (Case No. 13-cv-3599) granted FindTheBest.com, Inc.'s motion for judgment on the pleadings and invalidated Lumen View Technology LLC's patent. Judge Cote's ruling in favor of FindTheBest.com, represented by Leventhal Law, found that the patent lacked any inventive ideas and failed to claim...

2013-10-31 12:26:51

SAN JOSE, Calif., Oct. 31, 2013 /PRNewswire/ -- Ariosa Diagnostics, Inc., won summary judgment yesterday in a patent infringement litigation involving U.S. Patent No. 6,258,540 against Sequenom, Inc., an exclusive licensee of the patent from Isis Innovations, Inc. The United States District Court for the Northern District of California invalidated the '540 patent at issue, giving Ariosa a complete victory in the case. The patent at issue is related to the detection of fetal cell-free...

2013-09-03 16:27:02

WASHINGTON, Sept. 3, 2013 /PRNewswire-USNewswire/ -- A patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF) "covers ineligible subject matter and was anticipated by and obvious" in view of earlier research, Consumer Watchdog and the Public Patent Foundation have told a federal appeals court. In a reply brief filed late last week in the U.S. Court of Appeals for the Federal Circuit seeking to invalidate the '913 patent issued by the Patent and...

2013-06-20 08:27:31

PISCATAWAY, N.J., June 20, 2013 /PRNewswire/ -- On June 13, 2013, the United States Supreme Court unanimously ruled that although isolated, natural gene sequences are unpatentable, cDNA (referred to as synthetic DNA) is officially considered patentable subject material. The ruling was issued after the court reviewed patents owned by Myriad Genetics Inc. in the high-profile case Association for Molecular Pathology v. Myriad Genetics. The patents claimed the genes BRCA1 and BRCA2, as well as...

2013-06-18 23:03:27

The Supreme Court recently gave its answer of “No” to the question of whether human genes were patent-eligible subject matter. The decision relegates industry reliance on the Patent Office´s grant of more than 3,000 patents over 30 years to a footnote for Congressional action. (PRWEB) June 18, 2013 The Supreme Court recently gave its answer of “No” to the question of whether human genes were patent-eligible subject matter. The decision relegates industry...

2013-06-13 16:25:54

BETHESDA, Md., June 13, 2013 /PRNewswire-USNewswire/ -- Today, The Supreme Court of the United States (SCOTUS), in a unanimous decision, held that natural isolated DNA is not patentable. This is a thrilling victory for patients and ACMG is proud to have been a plaintiff on this important case. "We hold that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated," Justice Clarence Thomas said. As background, with breast cancer...

2013-06-06 04:20:59

GHENT, Belgium, June 6, 2013 /PRNewswire/ -- The United States Patent and Trade Office (USPTO) has allowed Pronota's patent for the use of a blood-based biomarker LG3 in the decision-making process for the treatment of renal dysfunction. This is a major step forward for Pronota as it reconfirms the patentability of the use of biomarkers. A decision of the US Supreme Court in Mayo vs. Prometheus in March 2012 had questioned the patentability of the use of biomarkers as...

shutterstock_137314787
2013-05-12 08:46:02

redOrbit Staff & Wire Reports — Your Universe Online A Washington DC-based federal appeals court has ruled that patents held by an Australian electronic financial marketplace are not valid because they are too abstract to qualify for such intellectual property protection. The ruling, which was handed down on Friday, pertains to a computerized trading platform which had been patented by Alice Corporation, a firm which deals in trading risk management and investment contracts....

2012-01-20 12:06:00

ARLINGTON, Va., Jan. 20, 2012 /PRNewswire-USNewswire/ --Bloomberg BNA today announces the publication of the Seventh Edition of Patent Law and Practice, offering analysis of the most recent case law and new legislation, including the Leahy-Smith America Invents Act. (Logo: http://photos.prnewswire.com/prnh/20120110/DC33627LOGO) Patent Law and Practice was first published by the Federal Judicial Center in 1988 as a one-volume introduction to patent law for federal judges. Since that time,...